1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

        <em id="8sgz1"><label id="8sgz1"></label></em>
      2. <em id="8sgz1"><label id="8sgz1"></label></em>
        <em id="8sgz1"></em>
        <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

        <button id="8sgz1"></button>
        west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "血氨" 2 results
        • Effect of valproic acid coadministred with lamotrigine on epileptic patients' ammonia

          ObjectiveTo investigate the effect of valproic acid (VPA) coadministred with lamotrigine (LTG) on epileptic patients' ammonia and evaluate the influencing factors of elevated blood ammonia in epileptic patients.MethodsA retrospective analysis of clinical data from 146 patients with epilepsy (including newly diagnosed epilepsy patients) who were admitted to the Seventh Affiliated Hospital of Sun Yat-Sen University from May 2018 to April 2020 was performed. The patients were divided into no antiepileptic drug group (group A), VPA group only (group B) and VPA combined LTG group (group C), and the concentration of the blood ammonia of the patients were analyzed.ResultThe average ammonia levels in groups A, B and C were (18.14±1.19), (25.89±0.87) and (36.60±4.34) μmol/L, and the incidence of blood ammonia higher than normal were 2.77%, 8.89% and 20.0%, respectively.The difference between group B and group A and group C were statistically significant (P<0.05), the difference between group C and group A was statistically significant (P<0.05).ConclusionPatients with epilepsy who use VPA were at increased risk of blood ammonia and LTG can increase ammonia in epileptic patients who were treated with VPA. So when VPA was combined with LTG, more attention should be paid to ammonia of patient to avoid adverse reactions.

          Release date:2020-09-04 03:06 Export PDF Favorites Scan
        • 作后血氨水平作為驚厥性癲癇發作的生物標志物:一項前瞻性研究

          有報道指出全面性驚厥性癲癇發作(Generalized convulsive seizures,GCS)后出現短暫性高血氨癥(Transient hyperammonemia,THA),沒有足夠的證據證實與癲癇的關系。文章的目的是確定發作后THA是否可以區分不同類型的發作,如使用視頻腦電圖(VEEG)監測確認腦電變化。在前瞻性隊列中,篩選了所有進入癲癇監測單元并同意接受研究的成年患者(> 18歲)。血氨的基礎值以及在發作(所有患者)的60 min內、發作后24 h(只要有可能)的血氨水平均被檢測。根據VEEG,將患者進行分組,分別為GCS、心因性驚厥性非癇性發作(Psychogenic nonepileptic seizures with convulsions,PNES-C)或局灶性癲癇發作(Focal seizures,FS)。使用描述性統計和參數/非參數方法分析數據。納入患者78例,13例為GCS、8例為FS、9例為PNES-C。這些組在性別(P=0.04) 和血氨基礎值(P=0.02) 方面是不同的,但年齡無差異。三組之間發作后血氨水平較血氨基礎值的變化差異有統計學意義(P=0.004)。區分GCS與其他組差異的發作后血氨水平ROC曲線下面積為0.88[95%CI (0.69, 0.96)],表明檢測血氨水平是一種很好的用來區分GCS與其他發作的試驗。血氨水平≥80μmol/L可以準確為80%的患者分類(靈敏度53.9%,特異性100%)。VEEG監測為THA與GCS癲癇發作之間的關聯提供了客觀證據,并為今后關于確定發作后血氨水平作為GCS的廉價診斷試驗作用的研究奠定了基礎。

          Release date:2017-07-26 04:06 Export PDF Favorites Scan
        1 pages Previous 1 Next

        Format

        Content

          1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

            <em id="8sgz1"><label id="8sgz1"></label></em>
          2. <em id="8sgz1"><label id="8sgz1"></label></em>
            <em id="8sgz1"></em>
            <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

            <button id="8sgz1"></button>
            欧美人与性动交α欧美精品